Friday, August 06, 2021 7:37:28 AM
Bought starter position yesterday. In @ 21.70 > BYSI
New York Yankees and Duke Basketball
Recent BYSI News
- BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026 • GlobeNewswire Inc. • 06/02/2026 11:00:00 AM
- BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 05/18/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:13:11 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:00:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:30:42 PM
- BeyondSpring shares rise after narrower quarterly loss and pipeline advances (BYSI) • IH Market News • 05/13/2026 01:29:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:00:21 AM
- BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2026 11:00:00 AM
- BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:57:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:24:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:24:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:24:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:24:24 PM
- BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:36:23 PM
- BeyondSpring Files 2025 Annual Report on Form 10-K • GlobeNewswire Inc. • 03/25/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 12:30:13 PM
- BeyondSpring Reports 2025 Year-End Financial Results • GlobeNewswire Inc. • 03/25/2026 12:30:00 PM
- BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference • GlobeNewswire Inc. • 02/09/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 09:30:28 PM
- BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path • GlobeNewswire Inc. • 12/12/2025 12:00:00 PM
- BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-(L)1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025 • GlobeNewswire Inc. • 12/11/2025 12:00:00 PM
